Canada's Drug Agency | Métis Engagement Session

An online event where participants will learn about the Essential Prescription Drugs and Related Products list, discuss the process used to include or exclude products and update the list over time, and identify potential additions to the list.

To learn more about the context and development of the Essential Prescription Drugs and Related Products list (List), please read the Discussion Paper which will be emailed to participants on June 19th.

Why are we holding engagement sessions?

Sage Solutions, on behalf of Canada’s Drug Agency and it's Essential Prescription Drugs and Related Products Advisory Panel (Advisory Panel), is looking for input (through an Indigenous or Indigenous-serving lens) on:

• the process used to include or exclude products,

• the process proposed to update the List over time, and